Aart Jan van der Lely1. 1. Division of Endocrinology and Metabolism, Department of Internal Medicine, Erasmus Medical Center, Rotterdam, The Netherlands. a.vanderlelij@erasmusmc.nl
Abstract
BACKGROUND: A growing body of literature has profiled the complex identities and interactions of ghrelin analogues and their known and unknown receptors, which constitute the ghrelin system. In humans, acylated ghrelin (AG) induces a rapid rise in glucose and insulin levels. However, coadministration of unacylated ghrelin (UAG) counteracts this effect. Accumulating data support the existence of a specific receptor for UAG in addition to the corticotropin-releasing factor 2 receptor and the growth hormone secretagogue type 1a receptor. Preclinically, mice that overexpress UAG exhibit decreased body weight, food intake, free fatty acid levels and fat pad mass weight and moderately decreased linear growth. In humans, intravenous infusion of UAG in normal subjects enhances the early insulin response to meals, improves glucose metabolism and insulin sensitivity and inhibits lipolysis. CONCLUSIONS: AG and UAG play an important regulatory role in metabolism. Copyright 2009 S. Karger AG, Basel.
BACKGROUND: A growing body of literature has profiled the complex identities and interactions of ghrelin analogues and their known and unknown receptors, which constitute the ghrelin system. In humans, acylated ghrelin (AG) induces a rapid rise in glucose and insulin levels. However, coadministration of unacylated ghrelin (UAG) counteracts this effect. Accumulating data support the existence of a specific receptor for UAG in addition to the corticotropin-releasing factor 2 receptor and the growth hormone secretagogue type 1a receptor. Preclinically, mice that overexpress UAG exhibit decreased body weight, food intake, free fatty acid levels and fat pad mass weight and moderately decreased linear growth. In humans, intravenous infusion of UAG in normal subjects enhances the early insulin response to meals, improves glucose metabolism and insulin sensitivity and inhibits lipolysis. CONCLUSIONS: AG and UAG play an important regulatory role in metabolism. Copyright 2009 S. Karger AG, Basel.
Authors: R M Kiewiet; M J Hazell; M O van Aken; K van der Weerd; J A Visser; A P N Themmen; A J van der Lely Journal: J Endocrinol Invest Date: 2010-10-15 Impact factor: 4.256
Authors: Lorenzo Leggio; Anna Ferrulli; Silvia Cardone; Antonio Nesci; Antonio Miceli; Noemi Malandrino; Esmeralda Capristo; Benedetta Canestrelli; Palmiero Monteleone; George A Kenna; Robert M Swift; Giovanni Addolorato Journal: Addict Biol Date: 2011-03-11 Impact factor: 4.280
Authors: Jenny Tong; Ronald L Prigeon; Harold W Davis; Martin Bidlingmaier; Steven E Kahn; David E Cummings; Matthias H Tschöp; David D'Alessio Journal: Diabetes Date: 2010-06-28 Impact factor: 9.461
Authors: Jacob E Moose; Katelyn A Leets; Nilamber A Mate; John D Chisholm; James L Hougland Journal: Expert Opin Ther Pat Date: 2020-06-21 Impact factor: 6.674